Project Grant R01CA301488
Award Date
4/1/25
Completion Date
3/31/30
Dollars Obligated
$632K
Federal Agency
National Cancer Institute
Federal Grant Program
93.396
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) provides funding of $424,734.00 to the University of Illinois to develop a novel spatial proteomics approach that integrates 3D microscopy techniques with bottom-up proteomic assays. This innovative method will enable deep proteome profiling of specific immune cells located in different subregions of a tumor. The key product will be a workflow to spatially encode and analyze immune cell...
This Project Grant award from the National Cancer Institute's Cancer Biology Research program (CFDA 93.396) provides $222,027 to the University of Pittsburgh to develop novel computational methods for characterizing the mechanobiology of tumor microenvironments.
The key objectives are to: (1) create a computational imaging algorithm that can quantitatively capture the intrinsic mechanobiological properties of cellular and acellular components within 3D tumor microenvironments, using a...
This Project Grant award from the National Cancer Institute's Cancer Detection and Diagnosis Research program (CFDA 93.394) provides $400,000 in funding to Ramona Optics Inc., a small disadvantaged business manufacturer, to develop the MCAM-96 - a parallelized computational microscope platform for high-throughput live imaging of 3D tumor organoid models.
The key objectives of this award are to: 1) Produce new parallelized microscope hardware to simultaneously image 96 well plates with 2...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering, under the Discovery and Applied Research for Technological Innovations to Improve Human Health (CFDA 93.286) program, is for the development of an advanced computational super-resolution model to enhance the throughput and resolution of chemical imaging techniques such as stimulated Raman scattering (SRS) microscopy. The overarching objective is to create a novel "ChemdiffuSE" model based...
The National Cancer Institute awarded a $407,113 Project Grant (CFDA 93.396 - Cancer Biology Research) to Trustees of Boston University for the development of bio-orthogonal mid-infrared photothermal imaging technology to study cancer metabolism. This 3-year award, running from September 1, 2024 to August 31, 2027, aims to: 1) build a library of nitrile-based probes to sense molecular events in cancer cells; 2) develop nitrile-tagged small molecules to measure nutrient metabolism; and 3)...
This Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) provides $417,586 to The Broad Institute, Inc. to develop a robust, multi-omic spatial platform for profiling human tumors. The key products and services to be delivered under this 3-year award (8/1/2024 - 7/31/2027) include:
Extending the Broad Institute's recently invented "Slide-Tags" spatial genomics technology to enable the measurement of transcription, epigenetic states, and...
This Project Grant award of $465,028 from the National Cancer Institute's Cancer Biology Research program (CFDA 93.396) will fund research to advance functional mass spectrometry imaging (FMSI) methodology for monitoring dynamic physiological processes in tissues. The key products and services to be delivered include:
Evaluating bolus and constant infusion protocols for isotopologue administration to improve sensitivity and extend the observable metabolic window of the FMSI technique....
This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) to Northeastern University will develop a novel microfluidic droplet-based platform (MDP) technology to generate and analyze a 3D biomimetic multicellular immunogenic tumor model. The key objectives are to: (1) establish multiple levels of hypoxia within the tumor-chip for parallel processing; (2) investigate spatiotemporal interaction between the tumor microenvironment's cancer...
This $577,034 federal Project Grant award from the National Cancer Institute's Cancer Biology Research program (CFDA 93.396) will support research by the Sloan-Kettering Institute for Cancer Research on the role of cancer cell mechanics and the tumor microenvironment in metastasis and immunosurveillance. The key objectives are to:
Examine how distinct metastatic microenvironments affect cancer cell biomechanics and immune vulnerability in mouse models and human samples.
Determine if...
This Project Grant award from the National Cancer Institute's Cancer Biology Research program (CFDA 93.396) provides $404,994 to Aperture Bio, Inc. to determine the feasibility of using their cyclic immunofluorescent imaging platform for preclinical drug development and research applications in areas such as cell therapy manufacturing, regenerative medicine, and oncology. The goal is to evaluate if Aperture Bio's technology, which can stain and quantify cellular perturbations in live cells...